Head & Neck Cancer

Latest News

Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer | Image Credit: © freshidea - stock.adobe.com.
Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer

March 5th 2024

Patients with factors such as lymphovascular space invasion or positive glossectomy specimen margins may be considered for adjuvant radiotherapy to optimize disease control of tongue squamous cell carcinoma.

 Radiation Therapy Plus Chemo Yielded Increased Efficacy in HPV+ Oropharynx Cancer
Radiation Therapy Plus Chemo Yielded Increased Efficacy in HPV+ Oropharynx Cancer

March 4th 2024

Frontline pembrolizumab with or without chemotherapy appears to remain a standard of care for patients with recurrent or metastatic head and neck squamous cell carcinoma based on data from the LEAP-010 study.
Pembrolizumab/Lenvatinib Combo Shows Mixed Results in Recurrent/Metastatic HNSCC

March 1st 2024

The FDA grants clearance to an oral immobilization stent designed to redirect radiation to the target tumor area for patients with head and neck cancer.
FDA Clears Oral Stent Solution for Radiotherapy in Head and Neck Cancer

January 22nd 2024

After observing a prevalence of thyroid cancer among transgender female patients through clinical observation, a study was prompted by clinicians in order to determine if this is an issue in a larger population.
Thyroid Cancer Rates Are Higher Among Transgender Female Veterans

October 29th 2023

Video Interviews
Podcasts

More News